Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Guyana
Guyana: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.1% in 2024. ▬ Flat
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Guyana, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guyana stood at 0.1%. That is the highest value across all 10 years on record.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guyana peaked at 0.1% in 2015 and was at its lowest, 0.1%, in 2015.
That places Guyana 135th out of 247 countries with data for 2024, putting it in the middle of the range.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Guyana, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.1% | — |
| 2016 | 0.1% | +0.0% |
| 2017 | 0.1% | +0.0% |
| 2018 | 0.1% | +0.0% |
| 2019 | 0.1% | +0.0% |
| 2020 | 0.1% | +0.0% |
| 2021 | 0.1% | +0.0% |
| 2022 | 0.1% | +0.0% |
| 2023 | 0.1% | +0.0% |
| 2024 | 0.1% | +0.0% |
Guyana compared with similar countries
- Guyana's 0.1% is below the median for Latin America & Caribbean, which is 0.2%, 67% of the median. (40 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.1% | 0.1% | 0.1% | 5 |
Countries ranked near Guyana
- 135 Albania 0.1% compare
- 135 Algeria 0.1% compare
- 135 Armenia 0.1% compare
- 135 Australia 0.1% compare
- 135 Belize 0.1% compare
- 135 Bhutan 0.1% compare
- 135 Bolivia (Plurinational State of) 0.1% compare
- 135 China 0.1% compare
- 135 Denmark 0.1% compare
- 135 Dominican Republic 0.1% compare
- 135 Gambia 0.1% compare
- 135 Guam 0.1% compare
- 135 Hungary 0.1% compare
- 135 Israel 0.1% compare
- 135 Jordan 0.1% compare
- 135 Kyrgyzstan 0.1% compare
- 135 Lebanon 0.1% compare
- 135 Lithuania 0.1% compare
- 135 Malaysia 0.1% compare
- 135 Oman 0.1% compare
- 135 Paraguay 0.1% compare
- 135 Peru 0.1% compare
- 135 Romania 0.1% compare
- 135 Russian Federation 0.1% compare
- 135 Serbia 0.1% compare
- 135 Singapore 0.1% compare
- 135 Thailand 0.1% compare
- 135 Trinidad and Tobago 0.1% compare
- 135 Tunisia 0.1% compare
- 135 Ukraine 0.1% compare
- 135 Uzbekistan 0.1% compare
- 135 Russia 0.1% compare
More development goals data for Guyana
- Red List Index 0.7279 (2025)
- Number of refugees per 100,000 population, by country of origin 35.28 (2025)
- Manufacturing value added per capita 459.03 (2025)
- Number of transboundary breeds 29 (2025)
- Number of transboundary breeds (not extinct) 29 (2025)
- Number of transboundary breeds with unknown risk status 29 (2025)
- Number of local breeds with unknown risk status 11 (2025)
- Number of local breeds (not extinct) 11 (2025)
- Number of local breeds kept in the country 11 (2025)
- Infant deaths 385 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guyana?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Guyana was 0.1% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Guyana?
- The highest recorded value was 0.1% in 2015.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Guyana?
- The lowest recorded value was 0.1% in 2015.
- How does Guyana rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guyana ranks 135th out of 247 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Guyana?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Guyana data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).